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Abstract
Background: FIV infection frequently compromises pregnancy under experimental conditions and is accompanied
by aberrant expression of some placental cytokines. Trophoblasts produce numerous immunomodulators that play
a role in placental development and pregnancy maintenance. We hypothesized that FIV infection may cause
dysregulation of trophoblast immunomodulator expression, and aberrant expression of these molecules may
potentiate inflammation and compromise pregnancy. The purpose of this project was to evaluate the expression of
representative pro-(TNF-a, IFN-g, IL-1b, IL-2, IL-6, IL-12p35, IL-12p40, IL-18, and GM-CSF) and anti-inflammatory
cytokines (IL-4, IL-5, and IL-10); CD134, a secondary co-stimulatory molecule expressed on activated T cells (FIV
primary receptor); the chemokine receptor CXCR4 (FIV co-receptor); SDF-1a, the chemokine ligand to CXCR4; and
FIV gag in trophoblasts from early-and late-term pregnancy.
Methods: We used an anti-cytokeratin antibody in immunohistochemistry to identify trophoblasts selectively,
collected these cells using laser capture microdissection, and extracted total RNA from the captured cell
populations. Real time, reverse transcription-PCR was used to quantify gene expression.
Results: We detected IL-4, IL-5, IL-6, IL-1b, IL-12p35, IL-12p40, and CXCR4 in trophoblasts from early-and late-term
pregnancy. Expression of cytokines increased from early to late pregnancy in normal tissues. A clear, pro-
inflammatory microenvironment was not evident in trophoblasts from FIV-infected queens at either stage of
pregnancy. Reproductive failure was accompanied by down-regulation of both pro-and anti-inflammatory
cytokines. CD134 was not detected in trophoblasts, and FIV gag was detected in only one of ten trophoblast
specimens collected from FIV-infected queens.
Conclusion: Feline trophoblasts express an array of pro-and anti-inflammatory immunomodulators whose
expression increases from early to late pregnancy in normal tissues. Non-viable pregnancies were associated with
decreased expression of immunomodulators which regulate trophoblast invasion in other species. The detection of
FIV RNA in trophoblasts was rare, suggesting that the high rate of reproductive failure in FIV-infected queens was
not a direct result of viral replication in trophoblasts. The influence of placental immune cells on trophoblast
function and pregnancy maintenance in the FIV-infected cat requires additional study.
Introduction
Precisely-regulated placental and decidual immunomo-
dulatory molecules such as cytokines and chemokines
are necessary to establish and maintain pregnancy [1-6].
While many of the immunomodulators expressed at the
maternal-fetal interface are products of decidual
leukocytes such as T cells, NK cells, dendritic cells, and
macrophages [2,5,7], leukocytes are not exclusive produ-
cers of these molecules. Trophoblasts, including both
cytotrophoblasts and syncytiotrophoblasts, are fetal-
derived cells of epithelial origin that form the placental
chorionic villi. These cells contact and attach to the
maternal endometrium and serve as a barrier between
maternal and fetal blood supplies in human pregnancy
[8]. Trophoblasts are a source of many cytokines and
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placental development and parturition [9-11].
Mother-to-child transmission of HIV remains an
important source of pediatric infection worldwide [12].
The role that HIV-infected trophoblasts play in vertical
transmission and pregnancy outcome is incompletely
understood. In in vitro experiments using trophoblastic
cell lines, cells were efficiently infected with cell asso-
ciated virus [13], but not cell free virus [14] due to dif-
ferences in entry pathways into the cell. In the latter
case, virus production was marginally increased by treat-
ment with TNF-a and IL-1b. HIV infections can dysre-
gulate cytokine expression in trophoblasts [15,16]. It has
been speculated that aberrant expression of cytokines
results in placental inflammation, facilitating transfer of
the virus across inflamed membranes to infect the fetus
[16].
Using the FIV-infected cat model for lentivirus vertical
transmission, we demonstrated frequent reproductive
failure in litters delivered at early-or late-gestation by
cesarean section. Placental and fetal infection occurred
in nearly all pregnancies in FIV-infected queens [17,18].
We recently reported that FIV-infection during early-
and late-term gestation affects immunomodulator
expression, producing a pro-inflammatory microenviron-
ment at early, but not late pregnancy [19]. However, the
specific cell populations expressing the targeted immu-
nomodulators were not identified. In the present study,
we hypothesized that FIV infection may cause dysregula-
tion of immunomodulator expression in trophoblasts
and contribute to reproductive failure. Our objectives
were to determine whether feline trophoblasts microdis-
sected from early-and late-term placentas of infected
queens were infected with FIV, to quantify trophoblast
expression of representative pro-and anti-inflammatory
cytokines and other immunomodulators known to be
important in pregnancy, and to assess whether gene
expression was related to pregnancy outcome.
Methods
Animals and virus
All procedures utilizing cats (Felis domesticus) were per-
formed with approval of the Institutional Animal Care
and Use Committee of Mississippi State University. As
previously reported [17,18], cats were reproductively
mature, specific-pathogen-free (SPF) animals of less
than 12 months of age when obtained from a commer-
cial cattery. Ten cats were inoculated intravenously with
1 ml of a feline plasma pool containing approximately
1.3 × 10
4 copies/ml of FIV-B-2542 (provided by Dr.
Edward Hoover) [20]. Ten cats were uninoculated and
served as normal controls. Infection was confirmed
within 6 weeks p.i. by detection of FIV provirus by PCR
and for seroconversion using the PetChek
® FIV
Antibody Test Kit (IDEXX Laboratories, Inc., West-
brook, ME), then queens were allowed to breed natu-
rally with SPF toms. Toms used to breed uninfected
females were never exposed to infected females and vice
versa. Breeding was observed and pregnancy was con-
firmed by palpation and ultrasonography.
Kittens were delivered by cesarean section during
week 3 gestation (early-term)[18] and week 8 gestation
(late-term) [17]. Placentas were collected under sterile
conditions using the following dissection procedure. The
uteri were removed and individual gestational sacs were
collected. Following rinses with sterile PBS, sacs were
incised with a sterile scalpel, and fetuses and placentas
were collected. Placental tissues were snap frozen in
liquid nitrogen and cryopreserved at -80°C. The effect of
FIV infection on fetal viability at early-and late-term
pregnancy was previously reported [17,18]. For this
study, we evaluated placental samples from both early-
and late-term gestation, including placentas from viable
and non-viable pregnancies. The placental tissues used
in this study are listed in Table 1.
Immunohistochemistry (IHC) to detect trophoblasts
All IHC procedures were performed using RNase-free,
sterile conditions according to established protocol
using polyclonal antibody to cytokeratin to label tropho-
blasts [21]. To enhance the capture of trophoblasts by
laser capture microdissection (LCM), sections were
dehydrated in 75%, 95%, and 100% ethanol. Sections
were then placed in undiluted xylene until LCM was
performed.
Laser capture microdissection to capture trophoblasts
Following immunohistochemical detection in placental
specimens, trophoblasts were microdissected using the
Veritas™ Microdissection Instrument (Arcturus
B i o s c i e n c e ,I n c . ,M o u n t a i n V i e w ,C A ) .M i c r o d i s s e c t i o n
was performed using the Capture IR laser (Power: 70
mW; Pulse: 2500 μsec; and Intensity: 200 mV) and UV
Cutting laser (Laser spot size: ~8.0 μm and Laser power:
7.0 mW). Similar-sized fields of ~2.00 mm
2 were col-
lected onto CapSure Macro LCM Caps (Arcturus). All
sections and capture areas were photographed using the
dissection instrument.
RNA purification and quantification from microdissected
tissues
RNA was extracted from microdissected trophoblasts of
FIV-B-2542-infected and uninfected queens at early
gestation (n = 5 and n = 3, respectively) and late gesta-
tion (n = 5 and n = 3, respectively), using the PicoPure
RNA Isolation Kit (Arcturus). All RNA samples were
treated with DNase to remove contaminating genomic
DNA. RNA was quantified using the NanoDrop™ 3300
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tham, MA). All RNA was stored at -80°C until used.
Reverse transcription-PCR to generate cDNA
Using the following cycling program: 25°C, 10 min; 37°C,
120 min; 85°C, 5 sec; 4°C, hold, cDNA was synthesized
using the High Capacity cDNA Reverse Transcription Kit
(Applied Biosystems, Inc., Foster City, CA) according to
the manufacturer’s instructions. Briefly, each reverse
transcription reaction was performed in a final reaction
volume of 20 μlc o n t a i n i n g2μl of the 10X RT buffer, 2
μl RT random primers, 0.8 μlo f2 5 Xd N T P ,1μl of Mul-
tiscribe Reverse Transcriptase, 1 μlR N a s ei n h i b i t o r ,3 . 2
μl of RNase-free water, and 10 μl of 30-800 pg RNA tem-
plate. All cDNA was stored at -20°C until used.
Primer design of feline immunomodulators and internal
control
The immunomodulators evaluated were representative
pro-(TNF-b,I F N - g,I L - 1 b, IL-2, IL-6, IL-12p35, IL-
12p40, IL-18, and GM-CSF) and anti-inflammatory
(IL-4, IL-5, and IL-10) cytokines; CD134, a secondary
co-stimulatory molecule expressed on activated T cells
(FIV primary receptor); CXCR4, a chemokine receptor
(FIV co-receptor); and SDF-1a, the chemokine ligand to
CXCR4. All the immunomodulators were known to be
expressed in placental/decidual tissues and important to
the establishment and maintenance of pregnancy.
Sequences of PCR primers and TaqMan probes specific
for feline immunomodulators and the housekeeping
gene b-actin were either designed as previously reported
[19,22] or obtained from the literature [17,23-26]. The
primer/probe sequences are listed in Table 2.
Evaluation of expression of immunomodulators using
TaqMan real-time PCR
The real-time PCR (qPCR) used an iCycler (Bio-Rad) and
the following cycling program: 50°C, 2 min; 95°C, 10 min;
60 X (95°C, 15 s; 60°C, 1 min). Each reaction contained 10
μlo ft h e2 XT a q M a n
® Universal PCR Master Mix
(Applied Biosystems, Life Technologies Corp., Carlsbad,
CA), 1 μl of forward and reverse primers (10 pmol/μl), 1
μl of the respective probe (100 fmol/μl), and ~2-4 μg
cDNA. For every placental cDNA sample, parallel reac-
tions were performed in triplicate simplex reactions on
separate plates for each gene. Due to the low concentra-
tion of RNA isolated from extracted cells, and conse-
quently, the limited amount of cDNA available for use in
qPCR, standard curves for internal control and target gene
amplicons were generated using pooled, serially-diluted
whole placental tissue RNA from representative unin-
fected cats. Each titration simplex reaction contained 6.25
μl of the 2X Thermoscript™ reaction mix, 0.25 μlo fT h e r -
moscript™ RT/Platinum
® Taq Mix (Invitrogen), 1 μlo f
forward and reverse primers (10 pmol/μl), 1 μlo ft h e
respective probe (100 fmol/μl), and five-fold diluted 2 μg
Table 1 Placental Tissue Evaluated in Study
Queen number and
placenta
Pregnancy
term
Queen FIV
status
Fetal viability Fetus FIV
Status
[17,27]
Placenta FIV status
[17,27]
Trophoblast
FIV
Status/Ct
value
2779 Placenta B Early - Viable NT NT -
2779 Placenta D Early - Viable NT NT -
2779 Placenta E Early - Non-viable;
resorption
NT NT -
0326 Placenta A Early + Viable + + -
8035 Placenta B Early + Non-viable; arrested - + -
8035 Placenta C Early + Non-viable; arrested + + -
0866 Placenta A Early + Viable + + -
0866 Placenta B Early + Non-viable;
resorption
++ -
9581 Placenta A Late - Viable NT NT -
9581 Placenta B Late - Viable NT NT -
9746 Placenta C Late - Viable NT NT -
9730 Placenta B Late + Viable + + -
9730 Placenta R1 Late + Non-viable;
resorption
-N T -
9730 Placenta R3 Late + Non-viable;
resorption
- + +/ > 37
13226 Placenta C Late + Non-viable; arrested + + -
13226 Placenta D Late + Non-viable; arrested + + -
NT = not tested
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were used to normalize for differences in PCR efficiency
between the internal control and target genes and between
sample plate runs. Differences in the amount of template
cDNA in each reaction was corrected by the cycle thresh-
o l d( C t )v a l u ef o rb-actin. Normalized samples were
divided by the calibration, generating the relative expres-
sion levels.
Statistical analysis
Statistical evaluation of fetal viability from early-and late-
term gestation was previously reported [17,18]. Statistical
analyses of immunomodulator expression for early-and
late-term control and FIV-B-2542-infected trophoblasts
were done using single-factor ANOVA and the two inde-
pendent sample Wilcoxon rank sum test (SOCR Analysis,
University of California, Los Angeles, CA).
Result
Microdissection of trophoblasts from placental tissues
Figure 1 shows a representative placental specimen fol-
lowing immunolabeling with anti-cytokeratin antibody
and laser capture microdissection of trophoblasts. Cyto-
keratin labeling was specific for trophoblasts [21].
Expression of FIV gag in trophoblasts
FIV gag was detected in only a single, late-term tropho-
blast specimen, collected from a placenta associated
Table 2 Primers and Probes used to Evaluate Immunomodulator and Virus Expression
Gene Primer Primer Sequence
(5’ to 3’)
Primer
Length
Probe Sequence (5’ to 3’) Accession # or
Reference
b actin Forward GACTACCTCATGAAGATCCTCACG 24 ACAGTTTCACCACCACCGCCGAGC AB051104
Reverse CCTTGATGTCACGCACAATTTCC 23
IL-1b Forward ATTGTGGCTATGGAGAAACTGAAG 24 TTTGCCTGCTCACAACCCCTCCAG M92060
Reverse TCTTCTTCAAAGATGCAGCAAAAG 24
IL-6 Forward GTGTGACAACTATAACAAATGTGAGG 26 CAAGGAGGCACTGGCAGAAAACAACCT L16914
Reverse GTCTCCTGATTGAACCCAGATTG 23
IL-10 Forward ACTTTCTTTCAAACCAAGGACGAG 24 TCTCGGACAAGGCTTGGCAACCCA AF060520
Reverse GGCATCACCTCCTCCAAATAAAAC 24
IL-
12p35
Forward ACACCAAGCCCAGGAATGTTC 21 AACCACTCCCAAACCCTGCTGCGA U83185
Reverse TGGCCTTCTGAAGCGTGTTG 20
IL-
12p40
Forward GAAGTACACAGTGGAGTGTCAGG 23 CAGTGCCTGCCCGGCTGCCG U83184
Reverse GGTTTGATGATGTCCCTGATGAAG 24
CD134 Forward CAGGTTATGGGATGGAGAGTCG 22 TGACCAGGACACCAAGTGCCTCCAGTG AY738589
Reverse TGCAAGGCTCGTAGTTCACG 20
CXCR4 Forward AAGGCAGTCCATGTCATCTACAC 23 ACCTCTACAGCAGTGTCCTCATCCTGGC AJ009816
Reverse AGACCACCTTTTCAGCCAACAG 22
SDF-1a Forward GCTACAGATGTCCTTGCCGATTC 23 TCGAGAGCCACGTTGCCAGAGCCA AB011965
Reverse TCTTCAGCCTCGCCACGATC 20
IL-2 Forward ACGGTTGCTTTTGAATGGAG 20 CCCCAAACTCTCCAGGATGCTCA Ref 23
Reverse CAATTCTGTGGCCTTCTTGG 20
IL-4 Forward CCCCTAAGAACACAAGTGACAAG 23 TTCTGCAGAGCCACAACCGTGC Ref 23
Reverse CCTTTGAGGAATTTGGTGGAG 21
IL-5 Forward TGCTTCTGCATTTGAGTTTG 20 TGGCAGAAACATAGGCAGCCCC Ref 23
Reverse CAGCCTATTCATGGGACTTTG 21
IL-18 Forward GGAGATCAACCTGTGTTTGAGGAT 24 ATTCTGACTGTACAGATAATGCACCCCGGAC Ref 25
Reverse GATGGTTACTGCCAGACCTCTAGTG 25
GM-CSF Forward AATGAAACGGTAGAAGTCGTCTCTG 25 TTGACCCTGAGGAGCCGAATTGCC Ref 26
Reverse CGTACAGCTTTAGGTGAGTCTGCA 24
IFN-g Forward TGGTGGGTCGCTTTTCGTAG 20 CATTTTGAAGAACTGGAAAGAGGAGAGTGATAAAACAAT Ref 24
Reverse GAAGGAGACAATTTGGCTTTGAA 23
TNF-a Forward CTTCTCGAACTCCGAGTGACAAG 23 TAGCCCATGTAGTAGCAAACCCCGAAGC Ref 26
Reverse CCACTGGAGTTGCCCTTCA 19
GAG Forward GTATGATCGTACTCATCCTCCTGAT 25 AGACCACTGCCCTACTTCACTGCCG Ref 17
Reverse TCTACATTGCATTCTGGCTGGT 22
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(greater than 37) indicated low level infection of this
trophoblast specimen. FIV gag was previously detected
in RNA from whole placental tissues using the same
protocol [27].
Expression of immunomodulators in trophoblasts
Messenger RNA for IL-4, IL-5, IL-6, IL-1b,I L - 1 2 p 3 5 ,
IL-12p40, and CXCR4 was expressed in all early-and
late-term trophoblasts. Messenger RNA for TNF-a,
IFN-g, IL-2, IL-18, IL-10, GM-CSF, CD134, and SDF-1a
was not detected in trophoblasts from either stage of
pregnancy. All immunomodulators were amplified from
RNA extracted from whole placental tissues used for
generating standard curves (data not shown), indicating
that failure to detect some of them in trophoblasts was
not a result of inadequate qPCR conditions.
To determine normal feline trophoblast expression of
the detected immunomodulators between the two stages
of pregnancy, data obtained from control placentas from
early-and late-term were compared. Trophoblasts from
control cats at late gestation expressed more IL-4, IL-6,
IL-1b, IL-12p35, IL-12p40, and CXCR4 mRNA than tro-
phoblasts from control cats at early gestation (p < 0.05).
Only IL-5 did not differ between the two stages of preg-
nancy (p = 0.135) (Figure 2A).
To determine the effect of FIV infection on expression of
these immunomodulators, trophoblasts from FIV-infected
and control queens at both early-and late-term gestation
were compared. At early gestation, the marginally-reduced
expression of nearly all immunomodulators in FIV-infected
cats did not reach the level of significance. The expression
of the anti-inflammatory cytokine IL-5 alone was decreased
to a significant level (p = 0.038) (Figure 2B). At late gesta-
tion, FIV-infection resulted in decreased expression of the
anti-inflammatory cytokine IL-4 (p = 0.021) and the pro-
inflammatory cytokine IL-12p35 (p = 0.021); decreased
expression of the pro-inflammatory cytokine IL-12p40 (p =
0.057) approached, but did not reach significance. There
was no significant effect on the expression of the remaining
immunomodulators (Figure 2C).
To determine whether cytokine expression was related
to fetal viability regardless of infection, trophoblasts
from all viable pregnancies were compared to tropho-
blasts from all non-viable pregnancies for both early-and
late-term gestation (Figure 3). At early gestation, tro-
phoblasts from non-viable pregnancies expressed signifi-
cantly less IL-4 (p = 0.032), IL-6 (p = 0.048), IL-12p35
(p = 0.001), and CXCR4 (p = 0.004) mRNA than those
of viable pregnancies (Figure 3A). The decreased IL-1b
expression in non-viable pregnancies approached, but
did not reach the level of significance (p = 0.052). At
late gestation, trophoblasts from non-viable pregnancies
expressed significantly less IL-4 (p = 0.021), IL-12p35 (p
= 0.021), and IL-12p40 (p = 0.038) than trophoblasts
from viable pregnancies (Figure 3B).
Discussion
Using the FIV-infected, pregnant cat to evaluate lenti-
virus-induced placental immunopathology and
Figure 1 Laser Capture Microdissection of IHC-stained Trophoblasts from a Representative FIV-negative Cat. Trophoblasts were labeled
using antibody to cytokeratin, and cytokeratin-positive trophoblasts were evident by brown staining. (A) Trophoblasts were selectively identified.
(B) Areas of trophoblast-rich populations were cut and captured using the UV cutting laser and Capture IR laser, respectively. (C) Selected
trophoblasts were removed from the tissue. (D) Trophoblasts were attached to the cap. All photography was performed with the 20X objective.
Bars = 200 microns.
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transfer of FIV-B-2542 at early-and late-term pregnancy
[17,18,28], with more than 50% of offspring infected.
We found fetal non-viability to be significantly higher in
FIV-infected queens at both stages of pregnancy [17,18].
While the mechanism of FIV-induced reproductive fail-
ure is unresolved, placental inflammation appears to
accompany FIV infection, especially at early pregnancy.
In a previous report by our laboratory which evaluated
immunomodulator expression in whole placental
specimens [19], an FIV-induced, pro-inflammatory
microenvironment at early, but not late pregnancy, was
evident, including increased expression of IL-6 and IL-
12, decreased expression of IL-10, and IL-12:IL-10 ratios
that favored the pro-inflammatory cytokine in infected
cats at early pregnancy.
In the present study, the effect of FIV infection on
immunomodulator expression in a targeted cell popula-
tion, trophoblasts, was evaluated at early and late gesta-
tion. Immunomodulators produced by trophoblasts play
Figure 2 Relative Expression of Immunomodulators in Trophoblasts from Early-and Late-Term Feline Placentas.R e a l - t i m eR T - P C R
analysis of feline placental trophoblast expression of the pro-inflammatory cytokines (IL-6, IL-1b, IL-12p35, and IL-12p40), the anti-inflammatory
cytokines (IL-4 and IL-5), and the chemokine receptor (CXCR4) in: (A) early-term uninfected placentas (n = 3) versus late-term uninfected
placentas (n = 3); (B) early-term FIV-infected (n = 5) versus uninfected placentas; (C) late-term FIV-infected (n = 5) versus uninfected placentas.
Bars represent mean Ct values substracted from a negative endpoint (60-mean Ct), bracketed by standard errors of the mean. P values obtained
from single factor ANOVA and Wilcoxon rank sum test are noted. P values ≤ 0.05 were considered significant.
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understanding how infections or perturbed pregnancy
correspond to altered gene expression specifically in tro-
phoblasts, in situ and in vitro, has been the focus of
many investigations [29-32]. We were able to detect
expression of IL-4, IL-5, IL-6, IL-1b, IL-12p35, IL-
12p40, and CXCR4 in feline placental trophoblasts at
both time points during feline gestation. The relative
expression of all immunomodulators increased in nor-
mal specimens as gestation progressed, indicating
increased immunomodulatory function of feline tropho-
blasts at late pregnancy. At early gestation, FIV infection
was associated with slightly decreased expression of all
cytokines, although only the expression of IL-5 (an anti-
inflammatory cytokine) decreased to significant levels.
At late gestation one anti-inflammatory cytokine (IL-4)
and one pro-inflammatory cytokine (IL-12p35) were
decreased in FIV-infected queens. The data suggest that
FIV infection of the queens caused a minor effect on
trophoblast function, and an FIV-induced pro-inflamma-
tory effect in trophoblasts was not clearly evident.
Non-viable pregnancies were accompanied by
decreased trophoblast expression of both pro-and anti-
inflammatory immunomodulators at early-(IL-4, IL-6,
IL-12p35, and CXCR4) and late-term (IL-4, IL-12p35,
and IL-12p40). One would predict reduced placental
function in dying pregnancies. However, decreased gene
expression was not significant for all immunomodula-
tors, suggesting that reduction in immunomodulator
function was not solely attributable to deterioriation of
the placenta in non-viable pregnancies. The decreased
expression of IL-4 and IL-6 in early placental tropho-
blasts from non-viable pregnancies parallels the IL-4
and IL-6 expression patterns found in the endometrial
tissue and deciduas of women with frequent implanta-
tion failures[33] and recurrent abortions [34]. IL-4 is a
Th2 cytokine that is mainly involved in the peri-implan-
tation period of placental development [35]. Along with
transforming growth factor-b (TGF-b), IL-4 mediates
the process of trophoblast invasion during human pla-
centation [36-39]. IL-4 and IL-6 contribute to the angio-
genesis of trophoblastic villi [40]. Silencing of IL-6 in
Figure 3 Relative Expression of Immunomodulators in Trophoblasts from Early-and Late-Term Feline Placentas from Viable and Non-
viable Pregnancies. Real-time RT-PCR analysis of trophoblast expression of the pro-inflammatory cytokines (IL-6, IL-1b, IL-12p35, and IL-12p40),
the anti-inflammatory cytokines (IL-4 and IL-5), and the chemokine receptor (CXCR4) in early-(A) and late-term (B) placentas from all viable (n = 4
each for early and late tissues) versus all non-viable (n = 4 each for early and late tissues) pregnancies. Bars represent mean Ct values
substracted from a negative endpoint (60-mean Ct), bracketed by standard errors of the mean. P values obtained from Wilcoxon rank sum test
are noted. P values ≤ 0.05 were considered significant.
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blast-like characteristics) using siRNA resulted in signifi-
cantly reduced proliferation of those cells [41]. IL-1b
activates matrix metalloprotease 3 (MMP-3), a protease
that digests extracellular matrix proteins and allows tro-
phoblast penetration of the maternal endometrium [42].
In the present study, the decrease in expression of IL-1b
approached significance (p = 0.052) at early pregnancy.
In the human placenta, CXCR4, expressed by tropho-
blasts, is also important in trophoblast invasion via
interaction with its ligand, SDF-1a, expressed on decid-
ual stromal cells [43]. In addition, this interaction pro-
tects trophoblasts from apoptosis via stimulation of
anti-apoptotic pathways [44]. IL-12, a heterodimeric
cytokine consisting of 35 and 40 kd protein subunits, is
also an important regulator of trophoblast invasion. It
inhibits trophoblast invasion by causing an IFN-g-depen-
dent reduction in expression of MMP-2, MMP-9, uroki-
nase-type plasminogen activator, and other proteases
that digest extracellular matrix proteins. IL-12 also
c a u s e sa ni n c r e a s ei ne x p r e s s i o no fi n h i b i t o r so ft h e s e
proteases [45]. The decreased expression of IL-4, IL-6,
IL-12p35, and CXCR4 in trophoblasts from early-term
non-viable pregnancies shows dysregulation of putative
mediators of feline trophoblast invasion during early
feline gestation, an outcome that could result in nutrient
and oxygen deprivation of the developing fetus and
account for the increased reproductive failure that
occurred in infected animals.
In contrast, cultured placental trophoblasts from HIV-
infected women expressed significantly higher amounts
of IL-1b,I L - 6 ,a n dT N F - a than placentas from unin-
fected women [16]. These data indicate that HIV-infec-
tion during pregnancy results in increased cytokine
expression and that a pro-inflammatory microenviron-
ment (an environment potentially conducive to vertical
transfer) exists in HIV-infected placentas. We did not
see this trend in trophoblasts collected from the cat
model. However, the study of human tissues used cul-
tured trophoblasts, whereas in the present study, RNA
was extracted from trophoblasts microdissected from
frozen placentas. Whether culturing the cells affected
gene expression is unknown.
While we previously reported the detection of mRNA
for the primary FIV receptor CD134 in whole feline pla-
cental tissues [46], we did not detect CD134 in any tro-
phoblast sample from early-or late-term pregnancy.
Correspondingly, FIV was detectable at a low level (Ct >
3 7 )i no n l yo n et r o p h o b l a s ts p e c i m e n ,ap l a c e n t af r o ma
late-term fetal resorption, indicating that trophoblasts
may not be highly susceptible or permissive to FIV infec-
tion. This result was surprising, given the high frequency
of fetal infection that was documented in these same cats
[17,18], and suggests that infected trophoblasts may not
be the source of fetal infection. We speculate that
immune cells in the surrounding microenvironment,
such as regulatory T cells (Tregs) or Th17 cells, the for-
mer of which are known to support the replication of
FIV [47,48], may influence trophoblast function and
serve as the source of fetal infection. Our laboratory is
currently investigating feline Tregs and Th17 cells in len-
tivirus-induced placental immunopathology and preg-
nancy failure.
A limitation of this study was the small number of tis-
sues evaluated by LCM, particularly in terms of separat-
ing viable versus non-viable tissues. LCM is a procedure
which is laborious, time-intensive, and expensive to per-
form, so limiting the samples collected was a necessity.
We attempted to minimize inter-cat variability by evalu-
ating multiple placentas from the same queen where
possible. The differences that we have historically
observed between placentas from the same queen
assured us that we can consider placentas from the
same queens as independent specimens [17,19,27]. Yet,
the inclusion of additional placental specimens may
have strengthened the statistical power and allowed us
to identify additional viral effects. In addition, it is
impossible to eliminate all cell contamination from the
microenvironment surrounding the trophoblasts due to
limitations in the precision of focusing the laser. How-
ever, our samples were highly enriched for trophoblasts,
as is evident by the well-defined tissue lifts that we were
able to achieve (Figure 1). LCM followed by qPCR has
been used as a means to collect trophoblasts from
whole placental specimens and measure gene expression
in these cells by others [49]. Regardless of the limita-
tions, this study provides novel information. Our pre-
vious reports clearly reveal that FIV infection results in
significantly higher rates of reproductive failure, prob-
ably by inducing placental immunopathology [17-19].
The present data shed additional light on this anomaly,
suggesting that aberrant expression of trophoblast cyto-
kines that may regulate trophoblast invasion accompa-
nies fetal demise.
Conclusion
Feline trophoblasts expressed an array of pro-and anti-
inflammatory immunomodulators whose expression
increased from early to late pregnancy in normal tissues,
while some immunomodulators that were expressed in
whole placental tissues were not detected. A virus-
induced, pro-inflammatory environment was not
detected in trophoblasts. Non-viable pregnancies were
associated with decreased expression of immunomodula-
tors which regulate trophoblast invasion in other spe-
cies, a finding which may explain the high rate of
reproductive failure in FIV-infected cats. The detection
of FIV RNA in trophoblasts was rare. This result
Scott et al. Virology Journal 2011, 8:336
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Page 8 of 10suggests that reproductive failure and altered tropho-
blast gene expression in FIV-infected queens was not a
direct result of viral infection of trophoblasts, but per-
haps was influenced by cells in the microenvironment
adjacent to trophoblasts. The effects of placental
immune cells on trophoblast function and pregnancy
maintenance in the FIV-infected cat requires additional
study.
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